FindTrial
Sign In

NGF for visual blindness in patient affected by glioma - ND

NGF for visual blindness in patient affected by glioma - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001438-29-IT
Enrollment
Unknown
Registered
2008-07-18
Start date
2008-05-15
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gloma with visual blindness MedDRA version: 9.1 Level: LLT Classification code 10030935 Term: Optic nerve glioma

Interventions

Product Name: Nerve Growth Factor -2.5S Pharmaceutical Form: Eye drops, solution CAS Number: 93928-24-6 Current Sponsor code: N6009 Concentration unit: mg milligram(s) Concentration type: equal Concen

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: children between 7-13 years old affected by glioma Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: na

Design outcomes

Primary

MeasureTime frame
Main Objective: efficacy;Secondary Objective: na;Primary end point(s): na—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026